Studies have found that activation of this signaling pathway can elevate the expression levels of NGF and its receptors in DRG cells, which then promotes the expression and secretion of SP and CGRP, exacerbating the pain of pancreatic cancer (98). This evidence concerns the gene NGF and pancreatic neoplasm.